In conclusion, ACE-inhibitory peptides produced from salmon bone hydrolysates have shown the potential to efficiently block ACE activity in vitro and may thus play a role in the development of future medications that may be used to address the problem of hypertension. The gene discussed is ACE; the disease is hypertensive disorder.